Ionis Pharmaceuticals, Inc. (IONS)
81.15
+0.55
(+0.68%)
USD |
NASDAQ |
Feb 27, 16:00
81.12
-0.03
(-0.04%)
After-Hours: 20:00
Ionis Pharmaceuticals Research and Development Expense (Annual) : 913.18M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.481B |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Geron Corp. | 73.72M |
| MannKind Corp. | 66.35M |
| Twist Bioscience Corp. | 80.28M |